BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10610481)

  • 1. Disseminated intravascular coagulation.
    Schmaier AH
    N Engl J Med; 1999 Dec; 341(25):1937-8. PubMed ID: 10610481
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical implications of analyses of fibrinogen and fibrin-derivatives in DIC].
    Magari Y; Ito M; Itoga T
    Rinsho Ketsueki; 1986 Oct; 27(10):1992-2007. PubMed ID: 3820619
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dynamics of blood coagulation and fibrinolysis and laboratory findings in disseminated intravascular coagulation].
    Madoiwa S
    Rinsho Ketsueki; 2010 Jan; 51(1):20-8. PubMed ID: 20134136
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison of results of fibrinogen degradation products (FDP) determination by immunologic methods and the results of other studies of the blood clotting system].
    Palester-Chlebowczyk M; Vertun B; Strzyźewska E; Królikiewicz K
    Pol Arch Med Wewn; 1977 Sep; 58(3):247-56. PubMed ID: 928163
    [No Abstract]   [Full Text] [Related]  

  • 5. Malignancies and disseminated intravascular coagulation.
    Yavasoglu I
    Asian Pac J Cancer Prev; 2013; 14(7):4459. PubMed ID: 23992020
    [No Abstract]   [Full Text] [Related]  

  • 6. Disseminated intravascular coagulation in geriatric patients.
    Matsuda T; Yokouchi M; Murakami M
    Bibl Haematol; 1983; (49):225-37. PubMed ID: 6667247
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative study of various rapid methods of determining fibrinogen transformation products in the diagnosis of intravascular coagulation and fibrinolysis].
    Lychev VG; Momot AP; Cherkashin GV
    Ter Arkh; 1984; 56(6):106-9. PubMed ID: 6474366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragmented red cells, thrombocytopaenia and elevated D-dimers do not always indicate the presence of disseminated intravascular coagulation, even in the presence of a bleeding tendency.
    Kurukulasuriya AP
    Ceylon Med J; 2003 Jun; 48(2):61. PubMed ID: 12971214
    [No Abstract]   [Full Text] [Related]  

  • 9. Distinction between fibrinogen and fibrin degradation products produced during disseminated intravascular coagulation in childhood.
    Yoshioka K; Mizuno S; Miyata H; Maki S
    Eur J Pediatr; 1982 Feb; 138(1):46-8. PubMed ID: 7075627
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fibrin/fibrinogen degradation products in diseases of the respiratory organs (a review of the literature)].
    Bodaretskiĭ GM; Bodaretskaia OI; Shekhter IE; Riabkova NV; Ena IaM
    Vrach Delo; 1990 May; (5):60-4. PubMed ID: 2204201
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biochemical studies in the postmortem diagnosis of the disseminated intravascular coagulation syndrome].
    Avramenko EP; Zoroastrov OM; Galian SL; Gladyshev SP; Lotter MG
    Sud Med Ekspert; 1998; 41(3):17-9. PubMed ID: 9703738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The importance of the enzyme preparation ancistron-N in the diagnosis of disseminated intravascular coagulation].
    Neĭko EM; Serediuk NN; Fabrika AV
    Vrach Delo; 1990 Apr; (4):57-60. PubMed ID: 2275170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of serum fibrinogen and fibrin fragments produced during disseminated intravascular coagulation.
    Lane DA; Preston FE; VanRoss ME; Kakkar VV
    Br J Haematol; 1978 Dec; 40(4):609-15. PubMed ID: 365218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ISTH overt disseminated intravascular coagulation score in patients with septic shock: automated immunoturbidimetric soluble fibrin assay vs. D-dimer assay.
    Gris JC; Faillie JL; Cochery-Nouvellon E; Lissalde-Lavigne G; Lefrant JY
    J Thromb Haemost; 2011 Jun; 9(6):1252-5. PubMed ID: 21645228
    [No Abstract]   [Full Text] [Related]  

  • 15. [Molecular markers of hemostatic mechanisms--FDP-D Dimer].
    Hada M
    Rinsho Byori; 1989 Mar; 37(3):240-7. PubMed ID: 2664280
    [No Abstract]   [Full Text] [Related]  

  • 16. [Characteristics of the disseminated intravascular coagulation syndrome in ischemic heart disease patients with congestive circulatory failure].
    Panchenko EP
    Kardiologiia; 1981 Aug; 21(8):50-5. PubMed ID: 7289383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation.
    Horan JT; Francis CW
    Semin Thromb Hemost; 2001 Dec; 27(6):657-66. PubMed ID: 11740689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [DIC: an application of new laboratory tests].
    Ikematsu S; Hada M; Kuroso K; Arai M
    Rinsho Ketsueki; 1986 Oct; 27(10):1984-91. PubMed ID: 3820618
    [No Abstract]   [Full Text] [Related]  

  • 19. [Progresses in characteristics and diagnostic methods of neonatal diffuse intravascular coagulation].
    Xu J; Pan XN
    Zhonghua Er Ke Za Zhi; 2013 Mar; 51(3):227-30. PubMed ID: 23751587
    [No Abstract]   [Full Text] [Related]  

  • 20. [Quantitative analysis of crosslinked fibrin degradation products (XDP) in several diseases].
    Saito M; Asakura H; Ito K; Joukaji H; Uotani C; Kumabashiri I; Matsuda T
    Rinsho Ketsueki; 1988 Nov; 29(11):2042-7. PubMed ID: 3236412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.